Literature DB >> 1000476

Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan. I. Epidemiologic observations.

N Takeichi, F Hirose, H Yamamoto.   

Abstract

An epidemiologic investigation was undertaken in Hiroshima to study the relationship of salivary gland tumors to exposure to ionizing radiation. Two hundred and eleven cases examined between 1953-1971 were confirmed by a review of histologic specimens. Of these, 66 cases occurred in residents of Hiroshima City who were born before the A-bomb: 30 among A-bomb-exposed, and 36 in non-exposed individuals. The incidence of salivary gland tumors among the exposed individuals was significantly higher, 2.6 times greater than that among the nonexposed individuals for all tumors, and 10 times greater for malignant tumors. The incidence increased with proximity to the hypocenter for the directly exposed. An increased incidence was also found among early entrants, particularly those entering the city within 3 days of the A-bomb.

Entities:  

Mesh:

Year:  1976        PMID: 1000476     DOI: 10.1002/1097-0142(197612)38:6<2462::aid-cncr2820380635>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Cancer incidence among employees of the Lawrence Livermore National Laboratory, 1969-1980.

Authors:  P Reynolds; D F Austin
Journal:  West J Med       Date:  1985-02

2.  Multiple malignant salivary gland neoplasms: mucoepidermoid carcinoma of palate and adenoid cystic carcinoma of floor of mouth.

Authors:  Joseph C Whitt; Duane R Schafer; Michael D Callihan
Journal:  Head Neck Pathol       Date:  2007-12-06

3.  Multiple primary cancers: with reference to atomic bomb survivors in Hiroshima.

Authors:  H Nakatsuka; M Nishiki; Y Kuroda; H Ezaki
Journal:  Jpn J Surg       Date:  1983-09

4.  Irradiation induced salivary gland neoplasia.

Authors:  S F Sener; E F Scanlon
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

5.  Second primary malignancies following salivary gland cancers.

Authors:  R J Biggar; R E Curtis; D A Hoffman; J T Flannery
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.